Akiyuki Suzuki

发表

A new strategy toward the total synthesis of stachyflin, a potent anti-influenza A virus agent: concise route to the tetracyclic core structure.

T. Katoh, M. Nakatani, M. Inoue, 2002, Organic letters.

Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure: results from phase I studies in Japanese patients

T. Mukohara, H. Minami, N. Kiyota, 2011, Investigational New Drugs.

Axitinib plasma pharmacokinetics and ethnic differences

R. Labadie, Y. Pithavala, M. Tortorici, 2015, Investigational New Drugs.

Population pharmacokinetics of tanezumab following intravenous or subcutaneous administration to patients with osteoarthritis or chronic low back pain

S. Shoji, S. Marshall, P. Gaitonde, 2022, British journal of clinical pharmacology.

[Quantitative Decision Making in Drug Development: Pharmacometrics].

Akiyuki Suzuki, 2016, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Evaluation of Crushed Tablet for Oral Administration and the Effect of Food on Apixaban Pharmacokinetics in Healthy Adults.

C. Frost, F. LaCreta, R. Frost, 2016, Clinical therapeutics.

Highly Improved Synthesis of (+)-Aureol via (-)-Neoavarone and (-)-Neoavarol, by Employing Salcomine Oxidation and Acid-Induced Rearrangement/Cyclization Strategy.

T. Katoh, M. Nakatani, M. Inoue, 2003 .

An efficient synthesis of (+)-aureol via boron trifluoride etherate-promoted rearrangement of (+)-arenarol

T. Katoh, M. Nakatani, M. Inoue, 2002 .

A New Strategy Toward the Total Synthesis of Stachyflin (I), a Potent Antiinfluenza A Virus Agent: Concise Route to the Tetracyclic Core Structure (II).

T. Katoh, M. Nakatani, M. Inoue, 2003 .

Clinical impact of genetic variants of drug transporters in different ethnic groups within and across regions.

Misaki Suzuki, Ichiro Ieiri, Katsuomi Ichikawa, 2013, Pharmacogenomics.

Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability – considerations for drug development

L. Tremaine, B. Feng, Y. Lai, 2012, Expert opinion on drug metabolism & toxicology.

A phase I study of the human anti‐activin receptor‐like kinase 1 antibody PF‐03446962 in Asian patients with advanced solid tumors

Y. Bang, K. Yoh, A. Ohtsu, 2016, Cancer medicine.

Measurement of Tactile Sensation on Human Hand by Static and Moving Two-point Discrimination Tests

Naotaka Sakai, Satoshi Shimawaki, S. Shimawaki, 2005 .

Highly Improved Synthesis of (+)-Aureol via (-)-Neoavarone and (-)-Neoavarol, by Employing Salcomine Oxidation and Acid-Induced Rearrangement/Cyclization Strategy

T. Katoh, M. Nakatani, M. Inoue, 2003 .

Pharmacokinetics and exploratory efficacy biomarkers of bococizumab, an anti-PCSK9 monoclonal antibody, in hypercholesterolemic Japanese subjects

K. Yokote, T. Teramoto, Yinhua Li, 2019, International journal of clinical pharmacology and therapeutics.

Does Industry‐Conducted All‐Case Surveillance of Newly Approved Oncology Drugs Contribute to the Revision of Package Inserts in Japan?

Hitoshi Sato, Y. Sasaki, Akiyuki Suzuki, 2019, Clinical and translational science.

Evaluation of Crushed Tablet for Oral Administration and the Effect of Food on Apixaban Pharmacokinetics in Healthy Adults.

C. Frost, F. LaCreta, R. Frost, 2016, Clinical therapeutics.

Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability – considerations for drug development

L. Tremaine, B. Feng, M. Varma, 2012, Expert opinion on drug metabolism & toxicology.

Abstract B15: Effect of axitinib (AG‐013736) on thyroid function and biomarkers: Results from phase I studies in Japanese patients

T. Mukohara, H. Minami, N. Kiyota, 2009 .